Holen Sie sich die Stockscreener-App
1.28
0.78%
-0.01
Handel nachbörslich:
1.28
Schlusskurs vom Vortag:
$1.29
Offen:
$1.28
24-Stunden-Volumen:
110.50K
Relative Volume:
0.68
Marktkapitalisierung:
$46.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.16M
KGV:
-2.2456
EPS:
-0.57
Netto-Cashflow:
$-8.75M
1W Leistung:
-3.03%
1M Leistung:
-7.25%
6M Leistung:
-13.51%
1J Leistung:
+8.47%
1-Tages-Spanne:
$1.23
$1.30
1-Wochen-Bereich:
$1.23
$1.35
52-Wochen-Spanne:
$0.75
$1.6899
Renovorx Inc Stock (RNXT) Company Profile
Firmenname
Renovorx Inc
Sektor
Branche
Telefon
408-800-2649
Adresse
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Vergleichen Sie RNXT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.28 | 48.28M | 0 | -9.16M | -8.75M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovorx Inc Aktie (RNXT) Neueste Nachrichten
What drives RenovoRx Inc. stock priceFree Market Dynamics Reports - jammulinksnews.com
What analysts say about RenovoRx Inc. stockRemarkably fast returns - Autocar Professional
RenovoRx Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com
Is RenovoRx Inc. a good long term investmentTurbocharged investment results - jammulinksnews.com
RenovoRx (NASDAQ:RNXT) Upgraded to Hold at Wall Street Zen - Defense World
What makes RenovoRx Inc. stock price move sharplyFree Premium Stock Market Reports - Newser
Why RenovoRx Inc. stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser
How RenovoRx Inc. stock performs during market volatilityFast Gains With Reduced Risk - Newser
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET - BioSpace
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14 - Business Wire
RenovoRx (NASDAQ:RNXT) Trading Down 2.9% – Should You Sell? - Defense World
Will RenovoRx (NASDAQ:RNXT) Spend Its Cash Wisely? - Yahoo Finance
RenovoRx shareholders elect directors and approve incentive plan amendments - Investing.com
RenovoRx Stockholders Approve Key Proposals at Annual Meeting - TipRanks
Short Interest in RenovoRx, Inc. (NASDAQ:RNXT) Declines By 35.4% - Defense World
Citadel Advisors LLC Invests $49,000 in RenovoRx, Inc. (NASDAQ:RNXT) - Defense World
RenovoRX chief medical officer buys $29,399 in common stock By Investing.com - Investing.com Canada
RenovoRX chief medical officer buys $29,399 in common stock - Investing.com Australia
Insider Buying: Ramtin Agah Acquires Additional Shares of RenovoRx Inc (RNXT) - GuruFocus
RenovoRx (NASDAQ:RNXT) Stock Rating Upgraded by Wall Street Zen - Defense World
RenovoRx (NASDAQ:RNXT) Given New $11.50 Price Target at Ascendiant Capital Markets - Defense World
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results - Yahoo Finance
Ascendiant Capital raises RenovoRx stock price target to $11.50 By Investing.com - Investing.com Canada
RenovoRx (RNXT) Price Target Increased by Ascendiant Analyst | R - GuruFocus
RenovoRx (RNXT) Price Target Increased by Ascendiant Analyst | RNXT Stock News - GuruFocus
RenovoRx (RNXT) Price Target Raised to $11.50 by Ascendiant Capi - GuruFocus
Finanzdaten der Renovorx Inc-Aktie (RNXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):